Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Group",
"id" : "172480",
"meta" : {
"versionId" : "7",
"lastUpdated" : "2023-12-04T16:22:54.673Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/outcome-definition"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Group 172480</b></p><a name=\"172480\"> </a><a name=\"hc172480\"> </a><a name=\"172480-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 7; Last updated: 2023-12-04 16:22:54+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-outcome-definition.html\">OutcomeDefinition</a></p></div><p><b>Artifact related artifact</b>: No display for RelatedArtifact (type: cite-as; citation: OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 172480. Revised 2023-11-02. Available at: https://fevir.net/resources/Group/172480. Computable resource at: https://fevir.net/resources/Group/172480.)</p><p><b>Artifact Author</b>: Brian S. Alper: </p><p><b>url</b>: <a href=\"https://fevir.net/resources/Group/172480\">https://fevir.net/resources/Group/172480</a></p><p><b>identifier</b>: FEvIR Object Identifier/172480</p><p><b>name</b>: OutcomeDefinition_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control</p><p><b>title</b>: OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years</p>\n</div><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><p><b>membership</b>: Conceptual</p><p><b>combinationMethod</b>: All of</p><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:{http://loinc.org 59261-8}\">Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol</span></p><p><b>value</b>: <7 %<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code% = '%')</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>hemoglobin A1c less than 7.0%</p>\n</div><h3>Timings</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>ContextCode</b></td><td><b>Offset[x]</b></td><td><b>Text</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 709491003}\">Enrollment in clinical trial</span></td><td>No display for Duration (value: 5; unit: years; system: http://unitsofmeasure.org; code: a)</td><td>at 5 years</td></tr></table></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:{http://loinc.org 2089-1}\">Cholesterol in LDL [Mass/volume] in Serum or Plasma</span></p><p><b>value</b>: <100 mg/dL<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM codemg/dL = 'mg/dL')</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>low-density lipoprotein cholesterol less than 100 mg/dL</p>\n</div><h3>Timings</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>ContextCode</b></td><td><b>Offset[x]</b></td><td><b>Text</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 709491003}\">Enrollment in clinical trial</span></td><td>No display for Duration (value: 5; unit: years; system: http://unitsofmeasure.org; code: a)</td><td>at 5 years</td></tr></table></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:{http://loinc.org 8480-6}\">Systolic blood pressure</span></p><p><b>value</b>: <130 mm Hg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM codemm[Hg] = 'mm[Hg]')</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>systolic blood pressure less than 130 mm Hg</p>\n</div><h3>Timings</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>ContextCode</b></td><td><b>Offset[x]</b></td><td><b>Text</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 709491003}\">Enrollment in clinical trial</span></td><td>No display for Duration (value: 5; unit: years; system: http://unitsofmeasure.org; code: a)</td><td>at 5 years</td></tr></table></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact",
"valueRelatedArtifact" : {
"type" : "cite-as",
"citation" : "OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 172480. Revised 2023-11-02. Available at: https://fevir.net/resources/Group/172480. Computable resource at: https://fevir.net/resources/Group/172480."
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail" : {
"name" : "Brian S. Alper"
}
}
],
"url" : "https://fevir.net/resources/Group/172480",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net",
"value" : "172480",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"name" : "OutcomeDefinition_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control",
"title" : "OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control",
"status" : "active",
"publisher" : "Computable Publishing LLC",
"contact" : [
{
"telecom" : [
{
"system" : "email",
"value" : "support@computablepublishing.com"
}
]
}
],
"description" : "The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years",
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"membership" : "conceptual",
"combinationMethod" : "all-of",
"characteristic" : [
{
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "59261-8",
"display" : "Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol"
}
]
},
"valueQuantity" : {
"value" : 7,
"comparator" : "<",
"unit" : "%",
"system" : "http://unitsofmeasure.org",
"code" : "%"
},
"exclude" : false,
"description" : "hemoglobin A1c less than 7.0%",
"timing" : [
{
"contextCode" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "709491003",
"display" : "Enrollment in clinical trial"
}
]
},
"offsetDuration" : {
"value" : 5,
"unit" : "years",
"system" : "http://unitsofmeasure.org",
"code" : "a"
},
"text" : "at 5 years"
}
]
},
{
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "2089-1",
"display" : "Cholesterol in LDL [Mass/volume] in Serum or Plasma"
}
]
},
"valueQuantity" : {
"value" : 100,
"comparator" : "<",
"unit" : "mg/dL",
"system" : "http://unitsofmeasure.org",
"code" : "mg/dL"
},
"exclude" : false,
"description" : "low-density lipoprotein cholesterol less than 100 mg/dL",
"timing" : [
{
"contextCode" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "709491003",
"display" : "Enrollment in clinical trial"
}
]
},
"offsetDuration" : {
"value" : 5,
"unit" : "years",
"system" : "http://unitsofmeasure.org",
"code" : "a"
},
"text" : "at 5 years"
}
]
},
{
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "8480-6",
"display" : "Systolic blood pressure"
}
]
},
"valueQuantity" : {
"value" : 130,
"comparator" : "<",
"unit" : "mm Hg",
"system" : "http://unitsofmeasure.org",
"code" : "mm[Hg]"
},
"exclude" : false,
"description" : "systolic blood pressure less than 130 mm Hg",
"timing" : [
{
"contextCode" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "709491003",
"display" : "Enrollment in clinical trial"
}
]
},
"offsetDuration" : {
"value" : 5,
"unit" : "years",
"system" : "http://unitsofmeasure.org",
"code" : "a"
},
"text" : "at 5 years"
}
]
}
]
}
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#2.0.0-ballot based on FHIR 6.0.0-ballot2. Generated 2024-12-19
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change